Published in Clin Immunol on June 12, 2011
CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol (2001) 9.19
The regulation of immunity to Leishmania major. Annu Rev Immunol (1995) 8.05
Effector and memory CTL differentiation. Annu Rev Immunol (2007) 7.17
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol (1998) 5.50
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A (1996) 5.26
Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance. Nature (2010) 3.68
Inflammatory cytokines as a third signal for T cell activation. Curr Opin Immunol (2010) 2.44
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol (1991) 2.02
Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med (1993) 1.98
Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol (2003) 1.84
Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J Immunol (1987) 1.64
Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol (2006) 1.62
Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol (2004) 1.60
Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med (1990) 1.57
Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol (1993) 1.50
Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells. J Immunol (1995) 1.46
CD8+ T regulatory cells express the Ly49 Class I MHC receptor and are defective in autoimmune prone B6-Yaa mice. Proc Natl Acad Sci U S A (2011) 1.41
Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice. Arthritis Rheum (2005) 1.40
Demystified ... microsatellites. Mol Pathol (2000) 1.06
Suppressive oligonucleotides protect against collagen-induced arthritis in mice. Arthritis Rheum (2004) 1.06
In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J Immunol (2002) 1.05
CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun Rev (2010) 1.04
Progression from acute to chronic disease in a murine parent-into-F1 model of graft-versus-host disease. J Immunol (2000) 1.03
Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation. Eur J Immunol (1995) 1.02
Expression of functional B7 and CTLA4 on rheumatoid synovial T cells. J Immunol (1994) 1.02
CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J Immunol (2008) 0.97
Allogeneic MHC antigen requirements for lupus-like autoantibody production and nephritis in murine graft-vs-host disease. J Immunol (1988) 0.97
Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J Invest Dermatol (1985) 0.96
TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms. J Immunol (2003) 0.94
The chronic graft-versus-host model of systemic autoimmunity. Curr Dir Autoimmun (2003) 0.94
Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE. Autoimmun Rev (2008) 0.94
Advances in lupus stemming from the parent-into-F1 model. Trends Immunol (2010) 0.90
Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression. Clin Immunol (2010) 0.87
A human microsatellite DNA-mimicking oligodeoxynucleotide with CCT repeats negatively regulates TLR7/9-mediated innate immune responses via selected TLR pathways. Clin Immunol (2010) 0.86
Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice. J Immunol (2011) 0.82
Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells. J Immunol (2010) 0.81
Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice. J Immunol (1997) 0.80
Effects of oligodeoxynucleotide with CCT repeats on chronic graft versus host disease induced experimental lupus nephritis in mice. Clin Immunol (2011) 0.79
Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array. Clin Immunol (2002) 1.21
Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol (2005) 1.09
Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease. J Immunol (2004) 1.09
In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function. J Immunol (2002) 1.05
CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J Immunol (2008) 0.97
Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease. Exp Mol Pathol (2005) 0.97
T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity. J Immunol (2007) 0.95
Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus. J Immunol (2007) 0.94
Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. Clin Immunol (2004) 0.91
Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J Immunol (2003) 0.89
Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression. Clin Immunol (2010) 0.87
Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses. J Immunol (2008) 0.86
Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease. Clin Immunol (2005) 0.85
Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. Arthritis Rheum (2003) 0.85
T cells, murine chronic graft-versus-host disease and autoimmunity. J Autoimmun (2012) 0.82
Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice. J Immunol (2011) 0.82
The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function. Methods Mol Biol (2012) 0.82
Enhancement of suboptimal CD8 cytotoxic T cell effector function in vivo using antigen-specific CD80 defective T cells. J Immunol (2010) 0.81
Cytokines in systemic lupus erythematosus. J Biomed Biotechnol (2011) 0.75